Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Ambu A/S       DK0060591204

AMBU A/S
Mes dernières consult.
Most popular
  Report  
End-of-day quote. End-of-day quote  - 01/03
114 DKK   +4.59%
06/08AMBU : The future of endoscopy is single-use
PU
06/07AMBU : becomes a C25 company on Nasdaq Copenhagen
PU
05/17AMBU A/S : Articles of Association
AQ
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq Omx Copenhagen
07/20/2016 07/21/2016 07/22/2016 07/25/2016 07/26/2016 Date
281 278.5 284 283 287 Last
19241 35642 22691 8300 10994 Volume
-0.71% -0.89% +1.97% -0.35% +1.41% Change
Financials (DKK)
Sales 2018 2 568 M
EBIT 2018 558 M
Net income 2018 345 M
Debt 2018 615 M
Yield 2018 0,20%
Sales 2019 2 937 M
EBIT 2019 701 M
Net income 2019 508 M
Debt 2019 522 M
Yield 2019 0,24%
P/E ratio 2018 152,06
P/E ratio 2019 113,07
EV / Sales2018 18,0x
EV / Sales2019 15,7x
Capitalization 45 638 M
More Financials
Company
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services.It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation.The Anaesthesia segment offers products from... 
More about the company
Surperformance© ratings of Ambu A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on AMBU A/S
06/08AMBU : The future of endoscopy is single-use
PU
06/07AMBU : becomes a C25 company on Nasdaq Copenhagen
PU
05/25AMBU : Patent Issued for Apparatus for Maintaining a Tensioned Pull-Wire in an E..
AQ
05/17AMBU A/S : Articles of Association
AQ
05/17AMBU A/S : Capital increase in connection with exercise of warrants issued
AQ
05/07AMBU A/S : Interim report for Q2 2017/18 and for the half-year (1 October 2017- ..
AQ
05/07AMBU : Half-year results
CO
05/02AMBU A/S : half-yearly earnings release
04/30AMBU : Completion of share buyback programme (no. 29)
PU
04/23AMBU : Transactions according to share buyback programme (no. 28)
PU
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart AMBU A/S
Duration : Period :
Ambu A/S Technical Analysis Chart | DK0060591204 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 200  DKK
Spread / Average Target -5,2%
EPS Revisions
Managers
NameTitle
Lars Marcher President & Chief Executive Officer
Jens Bager Chairman
Bjarne Nørgaard Sørensen Executive Vice President-Global Operations
Michael Højgaard Chief Financial Officer & Executive Vice President
Mikael Worning Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
AMBU A/S-1.98%7 137
MEDTRONIC PLC7.26%117 660
BAXTER INTERNATIONAL14.98%39 970
ALIGN TECHNOLOGY58.99%28 314
TERUMO CORP24.16%23 057
ZIMMER BIOMET HOLDINGS-7.59%22 718